購物車
幫助
021-54845833/15800441009
中文名稱 : 小鼠抗GCLC單克隆抗體
|
Background: |
Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.[provided by RefSeq, Oct |
|
Applications: |
WB, IHC |
|
Name of antibody: |
GCLC |
|
Immunogen: |
Fusion protein of human GCLC |
|
Full name: |
glutamate-cysteine ligase, catalytic subunit (GCLC), transcript variant 1 |
|
Synonyms: |
GCL; GCS; GLCL; GLCLC |
|
SwissProt: |
P48506 |
|
IHC positive control: |
human pancreas tissue and carcinoma of human thyroid tissue |
|
IHC Recommend dilution: |
30-150 |
|
WB Predicted band size: |
73 kDa |
|
WB Positive control: |
HepG2, A549, COS7, Jurkat, PC12, MCF-7 cell lysates |
|
WB Recommended dilution: |
200-1000 |
